Clinical Trials Browser

Phase NA × Hemostatic Disorders × Dipyrone × Clear all

NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Phase NA Recruiting

Agnosia, Hemostatic Disorders